Experiments were carried out with the suckling mouse cataract agent (SMCA) in an attempt to better characterize the nature of this agent. Despite the fact that high titers of SMCA were found in the chorioallantoic fluid of inoculated chicken embryos, the agent did not replicate in chicken embryo epithelial cell cultures. SMCA did not interfere with Sindbis virus plaque formation and was not inhibited by chicken interferon or polyinosinic-polycytidylic acid. The agent was relatively resistant to high pH and osmotic shock but was inactivated by low pH. Electron micrographs of negatively stained particles concentrated and semipurified from infected chicken embryo chorioallantoic fluids revealed pleomorphic particles ranging from approximately 70 to 400 nm in diameter. SMCA was resistant to kanamycin, novobiocin, and sodium aurothiomalate.
Experiments were carried out with the suckling mouse cataract agent (SMCA) in an attempt to better characterize the nature of this agent. Despite the fact that high titers of SMCA were found in the chorioallantoic fluid of inoculated chicken embryos, the agent did not replicate in chicken embryo epithelial cell cultures. SMCA did not interfere with Sindbis virus plaque formation and was not inhibited by chicken interferon or polyinosinic-polycytidylic acid. The agent was relatively resistant to high pH and osmotic shock but was inactivated by low pH. Electron micrographs of negatively stained particles concentrated and semipurified from infected chicken embryo chorioallantoic fluids revealed pleomorphic particles ranging from approximately 70 to 400 nm in diameter. SMCA was resistant to kanamycin, novobiocin, and sodium aurothiomalate.
The suckling mouse cataract agent (SMCA) was originally described by Clark in 1964 (7) . It was initially presumed to be a virus; however, subsequent studies have failed to yield conclusive evidence on this point (8-13, 16, 17) . Recent electron microscope observations suggested that SMCA may be a mycoplasma-like organism (Zeigel and Clark, J. Cell Biol. 43:163, 1969; Elizan and Schwartz, Abstr. Annu. Meet. Amer. Soc. Microbiol., p. 209, 1972). However, repeated attempts in this laboratory and by several other investigators have failed to cultivate SMCA on various types of Mycoplasma or pleuropneumonialike organism media (7; H. Fred Clark, personal communication). The present study was undertaken to characterize further the nature of SMCA.
MATERIAL AND METHODS Cultivation and quantitation of SMCA. SMCA was obtained from H. F. Clark in the form of early passage-infected chicken embryo chorioallantoic fluid (CAF) (7) . It was passaged an additional 17 times in this laboratory prior to the start of these studies. SMCA was propagated by inoculating 0.1 ml of undiluted CAF via the yolk sac of 7-day-old chicken embryos. The embryos were incubated at 37 C and candled daily to determine the time of death. The CAF were harvested when 50 to 80% of the embryos were found dead. This generally occurred between days 3 and 5 postinoculation (PI), depending upon the titer of the inoculum. The CAF from both live and dead embryos were pooled and samples were stored at -70 C. Infectivity titers ranged from 106. to 107-8 'Present address: Department of Biology, University of Oriente, Cumana, Venezuela. mean egg lethal doses (ELD50)/ml. All pools were checked for evidence of bacterial contamination by inoculating thioglycolate or brain heart infusion broth tubes. Infectivity titrations were performed by inoculating 0.1 ml of serial 10-fold dilutions (phosphate-buffered saline [PBS], pH 7.3) into each of three 7-day-old chicken embryos. Typical SMCA death patterns were observed (7), and only 2 to 3% of various control embryos (uninoculated, inoculated with normal CAF, and drug controls) died.
Drug inhibition experiments. The following were used: kanamycin sulfate (Bristol Laboratories, Syracuse, N.Y.), sodium novobiocin (Upjohn Co., Kalamazoo, Mich.), and sodium aurothiomalate (Merck, Sharp and Dohme, West Point, Pa.). The drugs were diluted in PBS (pH 7.3) to give the desired dosage in 0.1 ml. Seven-day-old chicken embryos were inoculated with 0.1 ml of drug via the yolk sac. After all eggs were inoculated, 0.1 ml of either undiluted or diluted SMCA was inoculated via the same route. The following controls were included in each experiment: embryos which received drug alone at the various concentrations tested, and untreated but SMCA infected embryos. The drugs were not toxic in the concentrations employed, as shown by lack of significant embryo lethality over periods of days 5 to 11 PI. Three methods were employed to evaluate efficacy of the drugs: (i) calculation of the average day of death, (ii) determination of SMCA yields at the time the embryos died, and (iii) growth curve experiments in the presence and absence of the various drugs.
Cell cultures and media. Chicken embryo fibroblast cell cultures were prepared by trypsinizing decapitated and minced whole 10-day-old chick embryos. The trypsinized cells were washed and resuspended in growth medium at a concentration of 2 x 10" cells per ml, and 5 ml was plated in 2-oz (about 60 ml) prescription bottles. The cultures were incubated at 37 C, and complete monolayers formed Interference and interferon experiments. Interference or interferon titrations were performed by a plaque inhibition assay procedure (24) . Sindbis virus was used as an indicator. Chicken embryo fibroblast monolayers were exposed to SMCA or SMCA-induced "interferon" preparations for various times. The inoculum was removed, and 0.2 ml of Sindbis virus diluted to give an estimated 50 to 100 plaques per monolayer was inoculated. The virus was adsorbed for 1 h at 37 C, the inoculum was removed, and the cultures were overlaid with 5 ml of agar overlay medium. The latter was the same as the maintenance medium described above, except that it contained a final concentration of 1% Noble agar (Difco). The cultures were incubated for 24 h at 37 C, and then a second agar overlay containing a 1: 10,000 dilution of neutral red was added. The plaques were counted after a further 12-to 24-h incubation period at 37 C.
Chick interferon was prepared by inoculating 10-day-old chicken embryos via the chorioallantoic cavity with influenza A virus, strain WSN. The embryos were incubated at 37 C for 24 h and chilled at 4 C, and the CAF were harvested and pooled. The pH was adjusted to approximately 2.0, and the CAF were held for 18 h at 4 C. The pH was adjusted to approximately 7.0, and the CAF were clarified by low-speed centrifugation. This preparation of crude chicken embryo interferon inhibited 50% of input Sindbis virus plaques at a dilution of 1 to 128.
SMCA interferon was prepared by inoculating aged 7-day-old chicken embryo fibroblast monolayers with 2 ml of undiluted SMCA-infected CAF (6) . After 1 h of incubation at 37 C, 5 ml of maintenance medium was added and incubation continued for an additional 24 h. The medium was removed and centrifuged at 30,000 rpm in a Spinco type 40 rotor for 5 h at 4 C. A control interferon preparation was prepared in the same manner-by inoculating 2 ml of undiluted normal CAF.
The polyinosinic-polycytidylic acid [poly(I) poly(C) ] was obtained commercially (Microbiological Associates, Bethesda, Md.).
Electron microscopy of SMCA. Approximately 400 ml of SMCA-infected CAF or CAF from noninoculated chicken embryos was used for each preparation. The concentration and purification procedure which made use of differential centrifugation has been described (4) . Final pellets were suspended in distilled water adjusted to pH 8.5 with NaOH (1 N) or PBS (pH 7.0). They were mixed with equal volumes of 2% sodium phosphotungstate (pH 6.0) and placed on carbon-coated grids. Excess fluid was removed, and the grids were air-dried. Observations were made with an RCA EMU-3F electron microscope at 50 kV and a direct magnification of x43,000. Calibration used carbon grating replica (2,160 lines/mm). SMCA that was passaged four times in the presence of 1,000 jAg of kanamycin per embryo was also concentrated and observed by the same techniques as described above.
RESULTS
Effect of kanamycin, novobiocin, and sodium aurothiomalate on SMCA. Seven-dayold chicken embryos were inoculated with various concentrations of drug or left untreated to serve as controls. The eggs were then inoculated with various concentrations of SMCA and candled daily for embryo deaths. In one of the kanamycin experiments, the yields of SMCA were determined ( Table 1 ). The survival time was not prolonged in any of the groups of drug-treated embryos. There was no supression of the yields of SMCA in the one kanamycin experiment where SMCA yields were determined.
As a more sensitive indication of possible inhibition, we performed growth curve experi- on October 16, 2017 by guest http://iai.asm.org/ Downloaded from ments with and without drugs. Lower challenge doses of SMCA were employed, and yields of SMCA were determined from day 1 through day 5 PI (Fig. 1-3 ). There were no significant differences in the growth curves performed in treated and control chicken embryos.
Growth curves and generation times of SMCA in chicken embryos. We calculated generation times during the periods of maximal increase shown in Fig. 1-3 . These varied between 3.5 and 5.2 h for the drug-treated growth curves ( Table 2 ). In the novobiocin experiment, there was an apparent prolongation of generation time; however, the difference was not as great as the differences found in the three control growth curves and is not considered significant. In support of this is the fact that yields of SMCA obtained at 3 and 5 days PI were the same for both novobiocin-treated and control embryos (Fig. 2) . Fig. 1-3 ELD5dml. The cultures were incubated for 1 h at 37 C, and then 5 ml of maintenance medium was added. The cultures were incubated at 37 C and examined daily for 6 days. There was no evidence for SMCA-induced cytopathology. One culture was harvested by freezing and thawing at 2, 4, and 6 days PI, and infectivity titrations were performed at the same time. The initial dilution of the inoculum in the cell culture fluids gave a calculated titer of 105-5 ELD5dml. At 2, 4, and 6 days the titers were 1028, 10"l, and 1016 ELD5dml, respectively. Thus, there was no evidence for replication in this cell culture system.
Interference and interferon studies with SMCA. Since the ability to produce interferon in cell culture is a rather wide spread attribute of viruses, we tried to gain indirect evidence for the presence of a virus in SMCA stocks by attempting to demonstrate interference or interferon production. Several dilutions of SMCA-infected CAF were inoculated (3.0-ml volumes) into chicken embryo fibroblast cultures. CAF from uninoculated chicken embryos were inoculated into cultures in one experiment to serve as controls. After incubation periods of 6 or 24 h at 37 C, the inoculum was removed and the cultures were challenged with Sindbis virus (Table 3) . Some inhibition of Sindbis virus plaque formation was observed; however, this occurred to approximately the same extent with both SMCA-infected and normal CAF. The results fail to reveal any evidence that SMCA can induce interferon or any other type of interference with Sindbis virus plaque development. SMCA-inoculated cultures that were not challenged with Sindbis were included as additional controls (not shown in Table 3 ). There were no plaques or any other forms of cytopathic effects observed when these cultures were overlaid with the agar medium and stained with neutral red.
An attempt was also made to demonstrate interferon production by inoculating SMCAinfected and normal CAF into aged 7-day-old Control (MM) 24 88 aChicken embryo cell cultures were exposed to 3 ml of SMCA-infected CAF, normal CAF, or diluent. After the specified exposure times (37 C), the inocula were removed, and 0.2 ml of Sindbis virus diluted to contain an estimated 50 to 100 plaques was used to infect each cell culture (three/group). The plaque assay was carried out as described in Materials and Methods.
'The diluent in experiment 1 was PBS; in experiment 2 it was maintenance medium (MM). Another characteristic shown by many viruses is that their replication can be inhibited by homologous interferon produced by unrelated viruses and by poly(I) -poly(C) (18) . Crude chicken embryo interferon or poly(I) -poly(C) was inoculated via the yolk sac of 7-dayold embryos. After overnight incubation at 37 C, the embryos were challenged with SMCA. Interferon and poly(I) -poly(C) controls and SMCA controls were included (Table 4 ). Both chicken interferon and poly(I) -poly(C) failed to prolong embryo survival time. The SMCA interferon and control interferon preparations produced in aged 7-day-old chicken embryo fibroblast cultures were also without effect.
Effects of pH and osmotic shock on infectivity of SMCA. Fractions of PBS were adjusted to pH 2, 5, 7, or 9 with 1% HCl or 7.5% NaHCO,. A 0.1-ml volume of undiluted SMCAinfected CAF was added to 4-ml samples at the various pH values and mixed well by vigorous pipetting. Incubation was at 4 C for 30 min, and then infectivity titrations were performed (Table 5) . SMCA was inactivated at the acid pH values, but was relatively stable at pH 9.0.
Initial experiments on the effect of osmotic shock on SMCA infectivity were conducted by diluting infected CAF into distilled water. Very little inactivation was demonstrable, presumably because of the residual low salt concentration from the CAF. SMCA-infected CAF was clarified by low-speed centrifugation and then pelleted at 30,000 rpm for 1 h. The pellets were carefully drained of residual CAF and suspended in distilled, deionized water or PBS (control). Incubation was at 37 C for 30 min, and then infectivity titrations were performed. The infectivity of the preparation suspended in distilled, deionized water was 2.0 logs lower than that suspended in PBS (10'-versus 101-3 ELD5Jml). Additional experiments revealed similar magnitudes of inactivation.
Electron microscopy. Pellets obtained by differential centrifugation of SMCA-infected chorioallantoic fluids were negatively stained with phosphotungstic acid and observed by electron microscopy. Pleomorphic particles ranging from 70 to 400 nm in diameter were observed (Fig. 4) . These were generally spherical in outline, and budding of dense spherules from larger particles were frequently observed. The size range and morphology of the particles were the same after four passages in the presence of kanamycin (1,000 ug/embryo). These aThe interferon (0.5 ml/embryo) and poly(I) -poly (C) preparations were inoculated via the yolk sac and after ovemight incubation at 37 C the embryos were challenged with SMCA (0.1 ml) via the same route.
Eight embryos per group. (1, 2, 25) . Thus, these experiments are compatible with the interpretation that SMCA is not viral in nature but is a mycoplasma-like organism.
The SMCA growth curves and generation times are also compatible with SMCA being a mycoplasma-like organism (Fig. 1-3 , Table 2 ). Mycoplasma growth curves are generally typical of bacterial growth curves and thus show lag, log, stationary, and death phases (23) . Although there are wide variations in mean generation times reported for Mycoplasma (23) , the mean generation times calculated for SMCA appear to be typical of many Mycoplasma. The relative degree of resistance shown by SMCA to osmotic shock is another characteristic shared by many Mycoplasma species (21, 22) .
Our initial experiments on drug inhibition were performed in an attempt to eliminate the mycoplasma-like organisms from our SMCA stocks. Since this was not possible, we performed additional drug inhibition experiments. These revealed a remarkable degree of resistance to kanamycin, novobiocin, and sodium aurothiomalate. High concentrations of these drugs failed to protect chicken embryos, and no significant differences were found in growth curves performed in drug-treated and untreated embryos ( Table 1 , Fig. 1-3) . Although the development of antibiotic resistance by various Mycoplasma species has been reported (3, 5, 20) , the degree of resistance shown by SMCA appears to be unusual-especially since resistance was observed with three drugs which presumably inhibit Mycoplasma by different modes of action and SMCA was not previously exposed to any of these. Mycoplasma resistant to kanamycin (600 ,ug/ml) in cell culture were described; however, the same Mycoplasma were sensitive to 50 ug of novobiocin per ml (3).
Kanamycin (2 to 200 ,g/ml) inhibited 34 of 36 strains of Mycoplasma, many of which were strains of Mycoplasma gallisepticum or other avian Mycoplasma (19) . Two other strains, one isolated from goats and one from turkey embryos, were resistant to 200 and 1,000 Mg/ml, respectively. Sodium aurothiomalate (0.025 ug/ ml) inhibited Mycoplasma in cell cultures (15) and 100 ,g/ml was sufficient to eliminate Mycoplasma from cell cultures and virus stocks (14) . Low concentrations of sodium aurothiomalate also inhibited many of the 36 strains described above. However, several strains were not inhibited by concentrations as high as 1,000 g/im1 (19 (26) , but lack of cultivation on artificial media makes it difficult to define SMCA as a Mycoplasma species at the present time.
